SERPINC1 抗体
(Serpin Family C Member 1 (SERPINC1))
The protein encoded by this gene is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. More than 120 mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency. [provided by RefSeq, Jul 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SERPINC1 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (C-Term) | 人, 小鼠, 大鼠, Cow, 犬, 马, 兔, 豚鼠, 绵羊 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (APC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (APC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (Biotin) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (Biotin) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (HRP) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (HRP) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (FITC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (FITC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (Fluoro488) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (Fluoro488) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (Fluoro550) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (Fluoro550) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (Cy3) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (Cy3) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (AA 89-464) (Fluoro647) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| SERPINC1 抗体 (N-Term) (Fluoro647) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 犬, 马, 兔, 豚鼠, 绵羊
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 89-464
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Latest Publications for our SERPINC1 抗体
: "LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy. Findings from the METEOR trial." in: International journal of cardiology, Vol. 271, pp. 247-253, (2019) (PubMed).
: "Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles." in: International journal of molecular sciences, Vol. 19, Issue 1, (2018) (PubMed).
: "Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma." in: Annals of hematology, Vol. 94, Issue 7, pp. 1167-74, (2015) (PubMed).
: "Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model." in: Proteome science, Vol. 9, pp. 73, (2011) (PubMed).
: "Effect of antithrombin III on neutrophil deformability." in: Journal of leukocyte biology, Vol. 78, Issue 3, pp. 777-84, (2005) (PubMed).
: "Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe(fat) mice." in: Cell, Vol. 88, Issue 1, pp. 73-83, (1997) (PubMed).
: "Intracellular misrouting and abnormal secretion of adrenocorticotropin and growth hormone in cpefat mice associated with a carboxypeptidase E mutation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 10, pp. 5314-9, (1997) (PubMed).
: "The C-terminal region of carboxypeptidase E involved in membrane binding is distinct from the region involved with intracellular routing." in: The Journal of biological chemistry, Vol. 271, Issue 11, pp. 6077-83, (1996) (PubMed).
: "Human carboxypeptidase E. Isolation and characterization of the cDNA, sequence conservation, expression and processing in vitro." in: The Biochemical journal, Vol. 267, Issue 2, pp. 517-25, (1990) (PubMed).
: "Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles." in: International journal of molecular sciences, Vol. 19, Issue 1, (2018) (PubMed).
: "Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma." in: Annals of hematology, Vol. 94, Issue 7, pp. 1167-74, (2015) (PubMed).
: "Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model." in: Proteome science, Vol. 9, pp. 73, (2011) (PubMed).
: "Effect of antithrombin III on neutrophil deformability." in: Journal of leukocyte biology, Vol. 78, Issue 3, pp. 777-84, (2005) (PubMed).
: "Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe(fat) mice." in: Cell, Vol. 88, Issue 1, pp. 73-83, (1997) (PubMed).
: "Intracellular misrouting and abnormal secretion of adrenocorticotropin and growth hormone in cpefat mice associated with a carboxypeptidase E mutation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 10, pp. 5314-9, (1997) (PubMed).
: "The C-terminal region of carboxypeptidase E involved in membrane binding is distinct from the region involved with intracellular routing." in: The Journal of biological chemistry, Vol. 271, Issue 11, pp. 6077-83, (1996) (PubMed).
: "Human carboxypeptidase E. Isolation and characterization of the cDNA, sequence conservation, expression and processing in vitro." in: The Biochemical journal, Vol. 267, Issue 2, pp. 517-25, (1990) (PubMed).
Aliases for SERPINC1 抗体
serpin family C member 1 (SERPINC1) 抗体antithrombin-III (CpipJ_CPIJ000472) 抗体
antithrombin-III (CpipJ_CPIJ013111) 抗体
serpin family C member 1 (Serpinc1) 抗体
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 (Serpinc1) 抗体
AI114908 抗体
ANTITHROMBIN, AT-III 抗体
At-3 抗体
AT-III 抗体
AT3 抗体
At3 抗体
AT3D 抗体
ATIII 抗体
DKFZp470C1733 抗体
SERPINC1 抗体
THPH7 抗体
您还需要查找其他产品吗？
- SERPINB9 抗体
- SERPINB8 抗体
- SERPINB7 抗体
- SERPINB6 抗体
- SERPINB5 抗体
- SERPINB4 抗体
- SERPINB3 抗体
- SERPINB2 抗体
- SERPINB13 抗体
- SERPINB12 抗体
- SERPINB11 抗体
- SERPINB10 抗体
- SERPINB1 抗体
- SERPINA9 抗体
- SERPINA7 抗体
- SERPINA6 抗体
- SERPINA5 抗体
- SERPINA4 抗体
- SERPINA3N 抗体
- SERPINA3 抗体
- SERPIND1 抗体
- SERPINE2 抗体
- SERPING1 抗体
- SERPINH1 抗体
- SERPINI2 抗体
- SERTAD1 抗体
- SERTAD2 抗体
- SERTAD3 抗体
- Serum Amyloid A 抗体
- serum/glucocorticoid Regulated Kinase 1 抗体
- serum/glucocorticoid Regulated Kinase 2 抗体
- Seryl-tRNA Synthetase 抗体
- SESN1 抗体
- SESN3 抗体
- SESTD1 抗体
- Sestrin 2 抗体
- SET and MYND Domain Containing 1 抗体
- SET and MYND Domain Containing 2a 抗体
- SET Binding Factor 2 抗体
- SET Domain Containing (Lysine Methyltransferase) 8 抗体
You are here:
